Abstract 483: Organoids-based high-throughput drug screening identifies selective vulnerability of AR-/lo CRPC to inhibitors of neurotransmission signaling.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148756283
Cites:
Cited by:
Related to: